|
CRC model (Model #1)
| | |
|
Colonoscopy indication—signs/symptoms (y/n)
|
0.665 (0.286)
|
1.94 (1.11–3.40)
|
|
Colonoscopy indication—history of polyps (y/n)
|
0.687 (0.277)
|
1.99 (1.16–3.42)
|
|
Colonoscopy indication—rectal bleeding (y/n)
|
0.773 (0.232)
|
2.17 (1.38–3.41)
|
|
Colonoscopy indication—anemia (y/n)
|
0.578 (0.257)
|
1.78 (1.08–2.95)
|
|
Age (years)
|
0.0432 (0.00926)
|
1.04 (1.03–1.06)
|
|
Charlson-Deyo co-morbidity score (0–1 vs. 2 +)
|
2.33 (0.224)
|
10.3 (6.65–16.0)
|
|
History of non-CRC malignancy (y/n)
|
2.73 (0.245)
|
15.3 (9.45—24.7)
|
|
Complete colonoscopy within past 10 years (y/n)
|
− 1.66 (0.256)
|
0.191 (0.116–0.315)
|
|
Residual CRC or HRA model (Model #2)*
|
|
Colonoscopy indication—CRC in FDR (y/n)
|
0.325 (0.114)
|
1.38 (1.11–1.73)
|
|
Colonoscopy Indication—history of polyps (y/n)
|
0.311 (0.158)
|
1.36 (1.001—1.86)
|
|
Age (years)
|
0.0384 (0.00783)
|
1.04 (1.02–1.06)
|
|
Sex (M/F)
|
− 0.470 (0.105)
|
0.625 (0.509–0.767)
|
|
# Years since any lower endoscopy
| | |
|
1–2
|
− 0.0762 (0.219)
|
0.927 (0.604–1.42)
|
|
2–4
|
− 1.09 (0.216)
|
0.336 (0.22–0.513)
|
|
4–6
|
− 0.766 (0.168)
|
0.465 (0.334–0.646)
|
|
6–8
|
− 0.541 (0.207)
|
0.582 (0.388–0.873)
|
|
8–10
|
− 0.0903 (0.258)
|
0.914 (0.552–1.51)
|
|
> 10 or none
|
Ref
|
Ref
|
|
Polyp treatment within past 10 years (y/n)
|
0.794 (0.157)
|
2.21 (1.63–3.01)
|
